These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19030730)

  • 1. Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list.
    Bonazzi PR; Bacchella T; Freitas AC; Osaki KT; Lopes MH; Freire MP; Machado MC; Abdala E
    Braz J Infect Dis; 2008 Aug; 12(4):306-9. PubMed ID: 19030730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list.
    Domínguez M; Bárcena R; García M; López-Sanroman A; Nuño J
    Liver Transpl; 2000 Jul; 6(4):440-2. PubMed ID: 10915165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response.
    Gutierrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martin JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1499-501. PubMed ID: 22841195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to a vaccination schedule with 4 doses of 40 microg against hepatitis B virus in cirrhotic patients evaluated for liver transplantation.
    Pascasio JM; Aoufi S; Gash A; Sousa JM; Perea R; Sayago M; Ferrer MT; Valencia R; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2943-5. PubMed ID: 19010154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low response rate to a vaccination against hepatitis B in patients with end-stage liver disease].
    Rožnovský L; Orságová I; Petroušová L; Tvrdík J; Kabieszová L; Rydlo M; Lochman I; Kloudová A
    Klin Mikrobiol Infekc Lek; 2010 Oct; 16(5):179-81. PubMed ID: 21191876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation.
    Villeneuve E; Vincelette J; Villeneuve JP
    Can J Gastroenterol; 2000; 14 Suppl B():59B-62B. PubMed ID: 10938507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation.
    Duca P; Del Pont JM; D'Agostino D
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):168-70. PubMed ID: 11321387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases.
    Di Paolo D; Lenci I; Trinito MO; Tisone G; Angelico M
    Dig Liver Dis; 2005 Oct; 37(10):793-8. PubMed ID: 16024302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination in liver transplant candidates.
    Castells L; Esteban R
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):359-61. PubMed ID: 11338062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].
    Zhang W; Lin CY; Han LL; Li LQ; Gao P; Lin H; Gong XH; Huang F; Tang YQ; Ma JX; Zhang HY; Wang C; Yang P; Li H; Sun MP; He X; Pang XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):767-70. PubMed ID: 21162840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.
    Cassidy WM; Watson B; Ioli VA; Williams K; Bird S; West DJ
    Pediatrics; 2001 Apr; 107(4):626-31. PubMed ID: 11335734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.